Related Experiment Video
Updated: Apr 19, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome
M Cohen1, J Harrington1, I Narang2
1Division of Endocrinology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Insights
Growth hormone (GH) deficiency is common in Prader-Willi syndrome (PWS). GH deficiency is less prevalent in infants under 18 months, suggesting careful age-based interpretation of GH stimulation tests is needed for PWS patients.
Area of Science:
- Pediatric Endocrinology
- Genetics and Genetic Diseases
- Metabolic Disorders
Background:
- Growth hormone (GH) deficiency is a frequent characteristic of Prader-Willi syndrome (PWS).
- Biochemical confirmation of GH deficiency in PWS is not always consistent.
- Current criteria for initiating GH treatment in pediatric PWS vary, with some nations requiring documented biochemical GH deficiency.
Purpose of the Study:
- To investigate age-related patterns in the prevalence of biochemical GH deficiency in infants and children diagnosed with PWS.
- To evaluate the significance of age in interpreting GH stimulation test results, particularly in the infant population with PWS.
Main Methods:
- A retrospective analysis of patient charts was performed.
- Data were collected from children diagnosed with PWS who underwent GH stimulation testing between 2000 and 2012 at a major pediatric hospital.
- The study reviewed charts of 47 children aged 0.4 to 15.5 years with PWS, assessing biochemical GH status relative to age and body mass index (BMI).
Main Results:
- Of the 47 patients, 32 (68%) exhibited biochemical GH deficiency.
- GH deficiency showed a significant correlation with older age (r=0.45, P=0.02) and higher BMI z-scores (r=0.45, P=0.02).
- Biochemical GH deficiency was notably less prevalent in children under 18 months (27%) compared to older children (81%; P=0.001), and more prevalent in obese patients (88%) versus non-obese patients (58%; P=0.04).
Conclusions:
- The diagnostic value of GH stimulation tests for assessing GH status in Prader-Willi syndrome patients under 18 months of age is questionable.
- Results from GH stimulation tests in young PWS patients should be interpreted with careful consideration of the patient's age.
- Age is a critical factor in the interpretation of GH stimulation test results for pediatric PWS.
Objective:
Growth hormone deficiency is a common feature of Prader-Willi syndrome; however, biochemical deficiency is not uniformly demonstrated. Criteria for GH treatment in paediatric PWS vary with some countries requiring documentation of biochemical GH deficiency. Data regarding the significance of age in the interpretation of GH stimulation test results, particularly in infants, are lacking. We aimed to assess age-related trends in the prevalence of biochemical GH deficiency in infants and children with PWS.
Design:
A retrospective chart review was conducted. Data from children with Prader-Willi syndrome that had GH stimulation tests performed at the Hospital for Sick Children in Toronto between the years 2000 and 2012 were collected.
Patient:
Charts of 47 children 0·4-15·5 years of age with PWS that had GH stimulation tests were reviewed.
Measurements:
Biochemical GH status in relation to age and body mass index.
Results:
Thirty-two of 47 patients (68%) were biochemically GH deficient. GH deficiency was significantly associated with older age (r = 0·45, P = 0·02) and higher body-mass-index z-score (r = 0·45, P = 0·02). Biochemical GH deficiency was less prevalent up to 18 months of age (3/11 27%) compared with older children (29/36 [81%]; P = 0·001). A higher prevalence of GH deficiency was also detected in obese patients (14/16 [88%]) compared with nonobese patients (18/31 [58%]; P = 0·04).
Conclusions:
The utility of performing GH stimulation tests as an indication of GH status under 18 months of age in Prader-Willi syndrome is questionable. If performed, results should be carefully interpreted in the context of age.
More Related Videos
10:25Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron dgn-destabilized Green Fluorescent Protein GFP-based Reporter Protein
Published on: November 10, 2012
09:39Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings
Published on: March 17, 2023
Related Concept Videos
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Hypoglycemia and Glucagon
Nature and Nurture
Signs of Puberty
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...